Association of male pattern baldness with angiographic coronary artery disease severity and collateral development. 2015

I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
Department of Cardiology, School of Medicine, Marmara University, Istanbul, Turkey, drisari@yahoo.com.

OBJECTIVE We aimed to investigate whether there is an association between male pattern baldness and angiographic coronary artery disease (CAD) severity and collateral development, which has not been reported previously. METHODS Coronary arteriograms, CAD risk factors, lipid parameters and presence and severity of baldness in 511 male patients were prospectively evaluated. Baldness was classified into five groups. Severity of CAD was evaluated with the Gensini scoring system and collateral development with Rentrop scores. RESULTS Although subjects with a higher Gensini score had more frequent and severe baldness, they were older than the group with lower Gensini scores. Bald patients had a higher Gensini score when compared with their non-bald counterparts. In univariate analysis, age more than 60, body mass index more than 30, smoking and baldness were predictors of high Gensini scores. In multivariate analysis, only age more than 60, body mass index more than 30 and smoking were independent predictors of a high Gensini score. There were no differences in terms of presence and severity of baldness in subjects with and without adequate collateral development. CONCLUSIONS There was no relation between presence, severity and age of occurrence of male pattern baldness and Gensini and Rentrop scores, which are important measures of presence and severity of CAD.

UI MeSH Term Description Entries

Related Publications

I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
May 2015, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 2020, Galen medical journal,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 2013, BMJ open,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
October 2009, Atherosclerosis,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 1983, Indian heart journal,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 2021, Disease markers,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 2005, Cardiology,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
January 2000, Archives of internal medicine,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
May 1998, Urology,
I Sari, and K Aykent, and V Davutoglu, and M Yuce, and O Ozer, and M Kaplan, and H Alici, and S Ercan, and M Sunbul, and K Tigen
February 2018, Urologic oncology,
Copied contents to your clipboard!